| |
| |
|
| Insider
Information: |
York Charles N Ii |
| Relationship: |
|
| City: |
Austin |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
259,655 |
|
|
Indirect Shares
|
11,560 |
|
|
| Direct
Value |
$20,897 |
|
|
|
Indirect Value
|
$6,944 |
|
|
| Total
Shares |
271,215 |
|
|
| Total
Value |
$27,841 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeglea Biotherapeutics, Inc. |
AGLE |
Chief Financial Office... |
2017-12-05 |
34,787 |
2016-04-12 |
11,560 |
Premium* |
|
|
Day One Biopharmaceuticals, Inc. |
DAWN |
|
2024-05-16 |
224,868 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Financial Officer and VP |
• – – |
2016-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,324 |
8,828 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Financial Officer and VP |
• – – |
2016-04-12 |
4 |
A |
$0.00 |
$0 |
I/I |
11,560 |
11,560 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Financial Officer and VP |
• – – |
2016-08-15 |
4 |
B |
$3.99 |
$7,974 |
D/D |
2,000 |
10,828 |
2.74 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Financial Officer and VP |
• – – |
2017-02-15 |
4 |
B |
$4.28 |
$8,568 |
D/D |
2,000 |
12,828 |
2.74 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Financial Officer and VP |
• – – |
2017-08-15 |
4 |
B |
$2.52 |
$4,929 |
D/D |
1,959 |
14,787 |
2.66 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Financial Officer and VP |
• – – |
2017-12-01 |
4 |
B |
$4.59 |
$29,855 |
D/D |
6,500 |
21,287 |
2.74 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Financial Officer and VP |
• – – |
2017-12-04 |
4 |
B |
$4.97 |
$16,197 |
D/D |
3,259 |
24,546 |
2.74 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Financial Officer and VP |
• – – |
2017-12-05 |
4 |
B |
$4.76 |
$48,700 |
D/D |
10,241 |
34,787 |
2.74 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-07-01 |
4 |
AS |
$20.00 |
$29,580 |
D/D |
(1,479) |
336,081 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-07-05 |
4 |
AS |
$20.00 |
$16,000 |
D/D |
(800) |
335,281 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-07-08 |
4 |
AS |
$20.00 |
$28,320 |
D/D |
(1,416) |
333,865 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-07-18 |
4 |
AS |
$20.00 |
$50,000 |
D/D |
(2,500) |
331,365 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-08-04 |
4 |
AS |
$20.05 |
$200,541 |
D/D |
(10,000) |
321,365 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
325,490 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-08-16 |
4 |
S |
$24.31 |
$26,474 |
D/D |
(1,089) |
324,401 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-09-01 |
4 |
AS |
$23.16 |
$232,484 |
D/D |
(10,000) |
314,401 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-10-03 |
4 |
AS |
$20.05 |
$200,473 |
D/D |
(10,000) |
304,401 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-11-01 |
4 |
AS |
$20.03 |
$200,313 |
D/D |
(10,000) |
294,401 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,375 |
295,776 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-11-16 |
4 |
S |
$21.46 |
$9,228 |
D/D |
(430) |
296,497 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-11-21 |
4 |
AS |
$20.74 |
$207,570 |
D/D |
(10,000) |
286,497 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2022-12-20 |
4 |
AS |
$20.07 |
$200,650 |
D/D |
(10,000) |
276,497 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2023-01-20 |
4 |
AS |
$22.75 |
$227,523 |
D/D |
(10,000) |
268,810 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,625 |
272,435 |
0 |
- |
|
| DAWN |
Day One Biopharmaceutical... |
COO, CFO and Secretary |
• – – |
2023-02-16 |
4 |
S |
$19.57 |
$18,203 |
D/D |
(930) |
271,505 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
